Ixico

Ixico company information, Employees & Contact Information

Updated May 2026

Quick answer

Ixico is a Biotechnology Research company and founded in 2004. It has approximately 84 employees on record. Contact data was last refreshed in May 2026. Find Ixico's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

Advancing medicine and human health by transforming data into clinically meaningful insights. IXICO is a premier neuroimaging provider helping biopharmaceutical companies maximize the value of their drug development pipelines by transforming data into clinically meaningful insights. Bringing together world-class therapeutic expertise, breakthrough analytics and operational excellence, IXICO is the proven partner of choice for imaging biomarker solutions in CNS clinical trials.

Company Details

Employees
84
Founded
-
Address
15 Long Lane, London,ec1a 9pn,united Kingdom
Phone
442076912064
Email
in****@****ico.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
ixico.com
HQ
London
Looking for a particular Ixico employee's phone or email?

Ixico Questions

News

IXICO Secures £1.2 Million in New Contracts and Extensions - TipRanks

IXICO Secures £1.2 Million in New Contracts and Extensions TipRanks

IXICO shares rise 4% on stronger-than-expected revenue growth - Proactive financial news

IXICO shares rise 4% on stronger-than-expected revenue growth Proactive financial news

How IXICO plc (PYPB) stock reacts to Fed tightening - Insider Selling & Comprehensive Market Scan Insights - Trung tâm Dự báo KTTV quốc gia

How IXICO plc (PYPB) stock reacts to Fed tightening - Insider Selling & Comprehensive Market Scan Insights Trung tâm Dự báo KTTV quốc gia

Neurological Rare Disease Biologics Market Size, Report by 2034 - Precedence Research

Neurological Rare Disease Biologics Market Size, Report by 2034 Precedence Research

IXICO CEO on biomarker strategy and growth - ICYMI - Proactive Investors

IXICO CEO on biomarker strategy and growth - ICYMI Proactive Investors

IXICO (LSE:IXI) Boosts Biomarker Research Amid FTSE 100 News - Kalkine Media

IXICO (LSE:IXI) Boosts Biomarker Research Amid FTSE 100 News Kalkine Media

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample | Schizophrenia - Nature

PSYSCAN multi-centre study: baseline characteristics and clinical outcomes of the clinical high risk for psychosis sample | Schizophrenia Nature

IXICO Reports Strong Revenue Growth and Strategic Investments in FY25 - TipRanks

IXICO Reports Strong Revenue Growth and Strategic Investments in FY25 TipRanks

How IXICO plc (PYPB) stock reacts to Fed tightening - Portfolio Gains Report & Weekly Hot Stock Watchlists - Trung tâm Dự báo KTTV quốc gia

How IXICO plc (PYPB) stock reacts to Fed tightening - Portfolio Gains Report & Weekly Hot Stock Watchlists Trung tâm Dự báo KTTV quốc gia

Ixico secures two agreements worth £1.2m - Sharecast.com

Ixico secures two agreements worth £1.2m Sharecast.com

IXICO reports revenue growth and upbeat outlook amid contract momentum - Proactive Investors

IXICO reports revenue growth and upbeat outlook amid contract momentum Proactive Investors

Market Recap: Can IXICO plc (PYPB) stock sustain revenue momentum - July 2025 Setups & Free AI Powered Buy and Sell Recommendations - Trung tâm Dự báo KTTV quốc gia

Market Recap: Can IXICO plc (PYPB) stock sustain revenue momentum - July 2025 Setups & Free AI Powered Buy and Sell Recommendations Trung tâm Dự báo KTTV quốc gia

IXICO plc to Host Capital Markets Day Highlighting Growth Strategy and Technological Advancements - TipRanks

IXICO plc to Host Capital Markets Day Highlighting Growth Strategy and Technological Advancements TipRanks

IXICO CEO on strong 2025 performance, 2026 priorities - Proactive financial news

IXICO CEO on strong 2025 performance, 2026 priorities Proactive financial news

IXICO shares climb 12% on £1.2m contract wins in biomarker testing - Proactive Investors

IXICO shares climb 12% on £1.2m contract wins in biomarker testing Proactive Investors

Will IXICO plc (PYPB) stock attract long term capital inflows - Breakout Watch & Low Volatility Stock Suggestions - Trung tâm Dự báo KTTV quốc gia

Will IXICO plc (PYPB) stock attract long term capital inflows - Breakout Watch & Low Volatility Stock Suggestions Trung tâm Dự báo KTTV quốc gia

Oxford BioDynamics, IP Group, Solvonis Therapeutics, IXICO, Light Science Technologies - Proactive Investors

Oxford BioDynamics, IP Group, Solvonis Therapeutics, IXICO, Light Science Technologies Proactive Investors

IXICO, Solvonis Therapeutics, Allergy Therapeutics, ANGLE, Anglo Asian Mining, Iofina - Proactive Investors

IXICO, Solvonis Therapeutics, Allergy Therapeutics, ANGLE, Anglo Asian Mining, Iofina Proactive Investors

Digital Biomarkers Market Size Expected to Reach USD 33.14 Bn by 2034 - BioSpace

Digital Biomarkers Market Size Expected to Reach USD 33.14 Bn by 2034 BioSpace

IXICO Revenues anticipated to be ahead of expectations for the year ending 30 September 2025 - Vox Markets

IXICO Revenues anticipated to be ahead of expectations for the year ending 30 September 2025 Vox Markets

IXICO secures £1.3m in new global neuroimaging contracts - Vox Markets

IXICO secures £1.3m in new global neuroimaging contracts Vox Markets

IXICO secures £1.2m contracts in biomarker testing and Alzheimer’s research - Proactive financial news

IXICO secures £1.2m contracts in biomarker testing and Alzheimer’s research Proactive financial news

IXICO: Blood test deal gives small-cap a shot in the arm - Proactive financial news

IXICO: Blood test deal gives small-cap a shot in the arm Proactive financial news

Is IXICO plc (LON:IXI) Potentially Undervalued? - Yahoo Finance

Is IXICO plc (LON:IXI) Potentially Undervalued? Yahoo Finance

IXICO plc Launches Retail Share Offer - TipRanks

IXICO plc Launches Retail Share Offer TipRanks

Ixico plc Announces New Blood Based Biomarker Contract Win and Contract Extension Worth A Total of £1.2 Million - MarketScreener

Ixico plc Announces New Blood Based Biomarker Contract Win and Contract Extension Worth A Total of £1.2 Million MarketScreener

Earnings Flash (IXI.L) Ixico Reports FY25 Revenue GBP6.5M - MarketScreener

Earnings Flash (IXI.L) Ixico Reports FY25 Revenue GBP6.5M MarketScreener

BSI whole-brain volume change estimation initialised with fully automatic LEAP segmentation - Wiley

BSI whole-brain volume change estimation initialised with fully automatic LEAP segmentation Wiley

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial - Nature

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial Nature

IXICO : CEO on strong 2025 performance, 2026 priorities - MarketScreener

IXICO : CEO on strong 2025 performance, 2026 priorities MarketScreener

IXICO plc CEO joins Zetta Genomics board - Business Weekly

IXICO plc CEO joins Zetta Genomics board Business Weekly

What are the Challenges in Developing New Treatments for Huntington's Disease? - News-Medical

What are the Challenges in Developing New Treatments for Huntington's Disease? News-Medical

IXICO: The brains behind brain scans - Vox Markets

IXICO: The brains behind brain scans Vox Markets

IXICO CEO on strong H1 performance, diversification and new verticals - Research Tree

IXICO CEO on strong H1 performance, diversification and new verticals Research Tree

Poolbeg Pharma, IXICO, ATOME, Caledonia Mining, Hercules - Small Cap Snapshot - Proactive Investors

Poolbeg Pharma, IXICO, ATOME, Caledonia Mining, Hercules - Small Cap Snapshot Proactive Investors

IXICO, Hercules, Thor Explorations, Ariana Resources, Buccaneer Energy, Sunda Energy - Small Cap Snapshot - Proactive Investors

IXICO, Hercules, Thor Explorations, Ariana Resources, Buccaneer Energy, Sunda Energy - Small Cap Snapshot Proactive Investors

Ixico raises expectations on new contract wins - Sharecast.com

Ixico raises expectations on new contract wins Sharecast.com

Ixico contracted for Alzheimer’s vaccine clinical trial - Fierce Biotech

Ixico contracted for Alzheimer’s vaccine clinical trial Fierce Biotech

The Evolution Of Medical Imaging In Clinical Research - Clinical Leader

The Evolution Of Medical Imaging In Clinical Research Clinical Leader

IXICO Plc (IXI.L) Share Price, Updates & RNS News - Vox Markets

IXICO Plc (IXI.L) Share Price, Updates & RNS News Vox Markets

Top Ixico Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant